Use and discontinuation of milrinone for advanced heart failure in an academic palliative care unit: a case report and discussion of recommendations

Article indépendant

WOLFE, Amanda | WATT, Christine L. | DOWNAR, James | BUSH, Shirley H.

The use of intravenous inotropic medications in advanced heart failure (HF) has been shown to improve symptoms and decrease hospitalizations, prompting support for their use as a palliative measure for symptom management. Recommendations regarding inotrope management and method of discontinuation at the end of life are not specifically detailed in the literature and current guidelines. This case report describes the use of milrinone in a patient with advanced HF during the terminal phase of illness in a non-monitored palliative care unit setting, including dose reduction and discontinuation of milrinone. Increased patient anxiety during the weaning process was managed with midazolam. The provision of individualized milrinone therapy in non-monitored palliative care settings is feasible and well-tolerated using the presented detailed recommendations for its use and administration, monitoring, dose reduction and discontinuation and proactive symptom management at the end of life. Further research is needed for the optimal management of terminally ill patients with advanced HF.Supplemental data for this article is available online at here. show.

https://www.tandfonline.com/doi/full/10.1080/15360288.2022.2027058

Voir la revue «Journal of Pain & Palliative Care Pharmacotherapy, 36»

Autres numéros de la revue «Journal of Pain & Palliative Care Pharmacotherapy»

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Gestion